P. Bourlioux

2.3k total citations
65 papers, 1.8k citations indexed

About

P. Bourlioux is a scholar working on Infectious Diseases, Molecular Biology and Food Science. According to data from OpenAlex, P. Bourlioux has authored 65 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 25 papers in Molecular Biology and 17 papers in Food Science. Recurrent topics in P. Bourlioux's work include Clostridium difficile and Clostridium perfringens research (24 papers), Gut microbiota and health (15 papers) and Probiotics and Fermented Foods (15 papers). P. Bourlioux is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (24 papers), Gut microbiota and health (15 papers) and Probiotics and Fermented Foods (15 papers). P. Bourlioux collaborates with scholars based in France, Belgium and United Kingdom. P. Bourlioux's co-authors include T. Karjalainen, Anne Collignon, C. Pelletier, Marie-Claude Barc, Anne‐Judith Waligora‐Dupriet, Philippe Pochart, Claire Hennequin, C. Bouley, Chantal Cayuela and Sylvie Bouttier and has published in prestigious journals such as American Journal of Clinical Nutrition, Applied and Environmental Microbiology and Clinical Infectious Diseases.

In The Last Decade

P. Bourlioux

63 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Bourlioux France 22 734 725 557 281 277 65 1.8k
D. W. S. Harty Australia 25 711 1.0× 425 0.6× 549 1.0× 252 0.9× 268 1.0× 42 2.3k
Maria Grazia Ammendolia Italy 29 754 1.0× 649 0.9× 401 0.7× 472 1.7× 367 1.3× 75 2.3k
P. Raibaud France 24 1.1k 1.5× 435 0.6× 731 1.3× 358 1.3× 109 0.4× 75 1.8k
Sylvie Hudault France 14 1.1k 1.5× 432 0.6× 912 1.6× 399 1.4× 90 0.3× 24 1.7k
Abdellah Benachour France 28 951 1.3× 620 0.9× 572 1.0× 154 0.5× 274 1.0× 55 2.0k
Malihe Talebi Iran 21 875 1.2× 417 0.6× 610 1.1× 209 0.7× 211 0.8× 88 1.7k
A. Satyanarayan Naidu Sweden 26 741 1.0× 470 0.6× 735 1.3× 872 3.1× 114 0.4× 54 2.2k
Dorota Czerucka France 24 919 1.3× 428 0.6× 1.0k 1.8× 457 1.6× 99 0.4× 37 2.1k
Christophe Lay Canada 22 1.5k 2.0× 442 0.6× 737 1.3× 385 1.4× 239 0.9× 26 2.1k
Catia Longhi Italy 26 625 0.9× 285 0.4× 470 0.8× 349 1.2× 288 1.0× 73 1.9k

Countries citing papers authored by P. Bourlioux

Since Specialization
Citations

This map shows the geographic impact of P. Bourlioux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Bourlioux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Bourlioux more than expected).

Fields of papers citing papers by P. Bourlioux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Bourlioux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Bourlioux. The network helps show where P. Bourlioux may publish in the future.

Co-authorship network of co-authors of P. Bourlioux

This figure shows the co-authorship network connecting the top 25 collaborators of P. Bourlioux. A scholar is included among the top collaborators of P. Bourlioux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Bourlioux. P. Bourlioux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alvarez, Anne‐Sophie, Julien Tap, Isabelle Chambaud, et al.. (2020). Safety and functional enrichment of gut microbiome in healthy subjects consuming a multi-strain fermented milk product: a randomised controlled trial. Scientific Reports. 10(1). 15974–15974. 21 indexed citations
2.
Juste, Catherine, Fernanda Fonseca, Patricia Lepage, et al.. (2018). Nouveaux dispositifs médicaux et nouveau procédé de fabrication pour un transfert de microbiote fécal par voie rectale, sans risque, standardisé et prêt à l’emploi. Journal de Pharmacie Clinique. 37(2). 73–83.
3.
Bourlioux, P.. (2013). De quelles alternatives notre arsenal thérapeutique anti-infectieux dispose-t-il face aux bactéries multi-résistantes ?. Annales Pharmaceutiques Françaises. 71(3). 150–158. 4 indexed citations
4.
Bourlioux, P., Christine Bouley, & Margaret Ashwell. (2003). New aspects of the functionalities of probiotics.. PubMed. 56. 355–6. 2 indexed citations
5.
Tasteyre, Albert, Marie-Claude Barc, T. Karjalainen, P. Bourlioux, & Anne Collignon. (2002). Inhibition of in vitro cell adherence of Clostridium difficile by Saccharomyces boulardii. Microbial Pathogenesis. 32(5). 219–225. 66 indexed citations
6.
Hennequin, Claire, Anne Collignon, P. Bourlioux, et al.. (2001). GroEL (Hsp60) of Clostridium difficile is involved in cell adherence. Microbiology. 147(1). 87–96. 187 indexed citations
7.
Bourlioux, P., et al.. (2000). Effects of subinhibitory concentrations of nitroxoline on the surface properties ofEscherichia coli. Folia Microbiologica. 45(6). 485–490. 15 indexed citations
8.
Guillou, Julien, et al.. (1999). Typing of sheep clinical isolates and identification of enterotoxigenicClostridium perfringensstrains by classical methods and by polymerase chain reaction (PCR). FEMS Immunology & Medical Microbiology. 24(3). 259–266. 31 indexed citations
9.
Bourlioux, P.. (1997). What is Currently Known About the Molecular Mechanisms of Colonisation Resistance. Anaerobe. 3(2-3). 179–184. 16 indexed citations
10.
Pelletier, C., et al.. (1997). Cell surface characteristics of Lactobacillus casei subsp. casei, Lactobacillus paracasei subsp. paracasei and Lactobacillus rhamnosus strains. Appl Environ Microbiol. 8 indexed citations
11.
Manuel, C, et al.. (1996). Répartition des sérotypes du virus de l'hépatite C en fonction des modes de contamination en milieu psychiatrique. Médecine et Maladies Infectieuses. 26(12). 1173–1176. 1 indexed citations
12.
Pelletier, C., P. Bourlioux, & Jean van Heijenoort. (1994). Effects of sub-minimal inhibitory concentrations of EDTA on growth ofEscherichia coliand the release of lipopolysaccharide. FEMS Microbiology Letters. 117(2). 203–206. 26 indexed citations
13.
Corthier, G., et al.. (1994). Barrier Effect of Normal Microbiota AgainstClostridium difficilemay be Influenced by Drugs Devoid of Antibiotic Activity. Microbial Ecology in Health and Disease. 7(6). 307–313. 4 indexed citations
14.
15.
Pochart, Philippe, Philippe Marteau, Yoram Bouhnik, et al.. (1992). Survival of bifidobacteria ingested via fermented milk during their passage through the human small intestine: an in vivo study using intestinal perfusion. American Journal of Clinical Nutrition. 55(1). 78–80. 158 indexed citations
16.
Bourlioux, P., et al.. (1991). Effect of fusafungine on adherence of Haemophilus influenzae type b to human epithelial cells in vitro. Biomedicine & Pharmacotherapy. 45(7). 301–306. 6 indexed citations
17.
Pochart, Philippe, Olivier Dewit, J F Desjeux, & P. Bourlioux. (1989). Viable starter culture, beta-galactosidase activity, and lactose in duodenum after yogurt ingestion in lactase-deficient humans. American Journal of Clinical Nutrition. 49(5). 828–831. 70 indexed citations
18.
Geniteau‐Legendre, Monique, et al.. (1989). Germ-free or holoxenic hairless mice: An experimental model for studying the cutaneous ILI activity. Journal of Investigative Dermatology. 93(2). 306. 3 indexed citations
19.
Su, Wen, et al.. (1986). Mise au point d'un modèle expérimental animal permettant l'étude de la microflore coecale du hamster, antagoniste de Clostridium difficile. Annales de l Institut Pasteur Microbiologie. 137(1). 89–96. 4 indexed citations
20.
Fourniat, J, et al.. (1982). [Influence of few components on bacteriostatic activity of some lipoaminoacids (author's transl)].. PubMed. 40(1). 3–10. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. W. S. Harty Breakdown of academic impact, for papers by Maria Grazia Ammendolia Breakdown of academic impact, for papers by P. Raibaud Breakdown of academic impact, for papers by Sylvie Hudault Breakdown of academic impact, for papers by Abdellah Benachour Breakdown of academic impact, for papers by Malihe Talebi Breakdown of academic impact, for papers by A. Satyanarayan Naidu Breakdown of academic impact, for papers by Dorota Czerucka Breakdown of academic impact, for papers by Christophe Lay Breakdown of academic impact, for papers by Catia Longhi
Rankless by CCL
2026